Caster, Ola http://orcid.org/0000-0002-2259-1716
Dietrich, Juergen
Kürzinger, Marie-Laure
Lerch, Magnus
Maskell, Simon
Norén, G. Niklas http://orcid.org/0000-0002-4595-230X
Tcherny-Lessenot, Stéphanie
Vroman, Benoit
Wisniewski, Antoni
van Stekelenborg, John
Funding for this research was provided by:
Innovative Medicine Initiative (115632)
Article History
First Online: 24 July 2018
Compliance with Ethical Standards
:
: The research leading to these results was conducted as part of the WEB-RADR consortium (ExternalRef removed), which is a public–private partnership coordinated by the Medicines and Healthcare products Regulatory Agency. The WEB-RADR project has received support from the Innovative Medicine Initiative Joint Undertaking (ExternalRef removed) under Grant Agreement No. 115632, resources of which are composed of financial contributions from the European Union’s Seventh Framework Programme (FP7/2007-2013) and the European Federation of Pharmaceutical Industries and Associations companies’ in-kind contribution.
: Magnus Lerch provided scientific advice and support to Bayer Pharma AG within the WEB-RADR project and has received compensation for his work from Bayer AG. Antoni Wisniewski is a full-time paid employee of AstraZeneca and holds shares in AstraZeneca. Ola Caster, Juergen Dietrich, Marie-Laure Kürzinger, Simon Maskell, G. Niklas Norén, Stéphanie Tcherny-Lessenot, Benoit Vroman and John van Stekelenborg have no conflicts of interest that are directly relevant to the content of this study.